Therapeutic controversy: Management of prolactinomas

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 996-1000

  Molitch, M E ^a   Thorner, M O ^a   Wilson, C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; PERGOLIDE; PROLACTIN; QUINAGOLIDE;

CLINICAL ARTICLE; ESTROGEN THERAPY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MALE; NOSE CONGESTION; NOTE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT OUTCOME; ARTICLE; TUMOR RECURRENCE;

BROMOCRIPTINE; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; PROLACTINOMA;

EID: 0031115932     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.996     Document Type: Note

References (19)